Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Serlie Mireille J.) > Definition and diag...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		07208naa a2200769 4500
001		oai:DiVA.org:uu-473562
003		SwePub
008		220502s2022 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4735622 URI
024	7	a https://doi.org/10.1016/j.clnu.2021.11.0142 DOI
040		a (SwePub)uu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Donini, Lorenzo M.u Sapienza Univ, Rome, Italy4 aut
245	1 0	a Definition and diagnostic criteria for sarcopenic obesity :b ESPEN and EASO consensus statement
264	1	b Elsevier,c 2022
338		a print2 rdacarrier
520		a Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated with a sedentary lifestyle, adipose tissue derangements, comorbidities (acute and chronic diseases), and during the ageing process. Co-existence of excess adiposity and low muscle mass/function is referred to as sarcopenic obesity (SO), a condition increasingly recognized for its clinical and functional features that negatively influence important patient-centred outcomes. Effective prevention and treatment strategies for SO are urgently needed, but efforts are hampered by the lack of an universally established SO Definition and diagnostic criteria. Resulting inconsistencies in the literature also negatively affect the ability to define prevalence as well as clinical relevance of SO for negative health outcomes.Aims and methods: The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) launched an initiative to reach expert consensus on a Definition and diagnostic criteria for SO. The jointly appointed international expert panel proposes that SO is defined as the co-existence of excess adiposity and low muscle mass/function. The diagnosis of SO should be considered in at-risk individuals who screen positive for a co-occurring elevated body mass index or waist circumference, and markers of low skeletal muscle mass and function (risk factors, clinical symptoms, or validated questionnaires). Diagnostic procedures should initially include assessment of skeletal muscle function, followed by assessment of body composition where presence of excess adiposity and low skeletal muscle mass or related body compartments confirm the diagnosis of SO. Individuals with SO should be further stratified into Stage I in the absence of clinical complications, or Stage II if cases are associated with complications linked to altered body composition or skeletal muscle dysfunction.Conclusions: ESPEN and EASO, as well as the expert international panel, advocate that the proposed SO Definition and diagnostic criteria be implemented into routine clinical practice. The panel also encourages prospective studies in addition to secondary analysis of existing datasets, to study the predictive value, treatment efficacy, and clinical impact of this SO definition. (c) 2022 The Author(s). Published by Elsevier Ltd. on behalf of European Society for Clinical Nutrition and Metabolism and Obesity Facts published by S. Karger AG. This article is published under the Creative Commons CC-BY license. All rights reserved.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng
653		a Obesity
653		a Sarcopenia
653		a Sarcopenic obesity
700	1	a Busetto, Lucau Univ Padua, Padua, Italy4 aut
700	1	a Bischoff, Stephan C.u Univ Hohenheim, Stuttgart, Germany4 aut
700	1	a Cederholm, Tommyu Uppsala universitet,Klinisk nutrition och metabolism4 aut0 (Swepub:uu)tomce419
700	1	a Ballesteros-Pomar, Maria D.u Complejo Asistencial Univ Leon, Leon, Spain4 aut
700	1	a Batsis, John A.u Univ N Carolina, Chapel Hill, NC 27515 USA4 aut
700	1	a Bauer, Juergen M.u Heidelberg Univ, Heidelberg, Germany4 aut
700	1	a Boirie, Yvesu Univ Clermont Auvergne, CHU Clermont Ferrand, CRNH, INRA, Clermont Ferrand, France.4 aut
700	1	a Cruz-Jentoft, Alfonso J.u Hosp Univ Ramon Y Cajal IRYCIS, Madrid, Spain4 aut
700	1	a Dicker, Droru Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel4 aut
700	1	a Frara, Stefanou San Raffaele Vita Salute Univ, Milan, Italy.;IRCCS Hosp, Milan, Italy4 aut
700	1	a Frühbeck, Gemau Clin Univ Navarra, IdiSNA, CIBEROBN, Pamplona, Spain4 aut
700	1	a Genton, Laurenceu Hop Univ Geneve, Geneva, Switzerland4 aut
700	1	a Gepner, Yftachu Tel Aviv Univ, Tel Aviv, Israel4 aut
700	1	a Giustina, Andreau San Raffaele Vita Salute Univ, Milan, Italy.;IRCCS Hosp, Milan, Italy4 aut
700	1	a Gonzalez, Maria Cristinau Catholic Univ Pelotas UCPEL, Pelotas, RS, Brazil4 aut
700	1	a Han, Ho-Seongu Seoul Natl Univ, Bundang Hosp SNUBH, Seoul, South Korea4 aut
700	1	a Heymsfield, Steven B.u Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA4 aut
700	1	a Higashiguchi, Takashiu Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan4 aut
700	1	a Laviano, Alessandrou Sapienza Univ, Rome, Italy4 aut
700	1	a Lenzi, Andreau Sapienza Univ, Rome, Italy4 aut
700	1	a Nyulasi, Ibolyau Monash Univ, Clayton, Vic, Australia4 aut
700	1	a Parrinello, Eddau Sapienza Univ, Rome, Italy4 aut
700	1	a Poggiogalle, Eleonorau Sapienza Univ, Rome, Italy4 aut
700	1	a Prado, Carla M.u Univ Alberta, Edmonton, AB, Canada4 aut
700	1	a Salvador, Javieru Univ Navarra, IdiSNA, CIBEROBN, Pamplona, Spain4 aut
700	1	a Rolland, Yvesu Toulouse Univ Hosp, Gerontopole Toulouse, INSERM 1027, Toulouse, France4 aut
700	1	a Santini, Ferrucciou Univ Pisa, Pisa, Italy4 aut
700	1	a Serlie, Mireille J.u Amsterdam Univ Med Ctr, Amsterdam, Netherlands4 aut
700	1	a Shi, Hanpingu Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China4 aut
700	1	a Sieber, Cornel C.u Friedrich Alexander Univ Erlangen Nurnberg, Nurnberg, Germany4 aut
700	1	a Siervo, Mariou Univ Nottingham, Nottingham, England4 aut
700	1	a Vettor, Robertou Univ Padua, Padua, Italy4 aut
700	1	a Villareal, Dennis T.u Baylor Coll Med, Houston, TX 77030 USA4 aut
700	1	a Volkert, Dorotheeu Friedrich Alexander Univ Erlangen Nurnberg, Nurnberg, Germany4 aut
700	1	a Yu, Jianchunu Peking Union Med Coll Hosp, Beijing, Peoples R China4 aut
700	1	a Zamboni, Maurou Univ Verona, Verona, Italy4 aut
700	1	a Barazzoni, Roccou Univ Trieste, Dept Med Surg & Hlth Sci, Str Fiume 447, I-34149 Trieste, Italy4 aut
710	2	a Sapienza Univ, Rome, Italyb Univ Padua, Padua, Italy4 org
773	0	t Clinical Nutritiond : Elsevierg 41:4, s. 990-1000q 41:4<990-1000x 0261-5614x 1532-1983
856	4	u https://doi.org/10.1016/j.clnu.2021.11.014y Fulltext
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-473562
856	4 8	u https://doi.org/10.1016/j.clnu.2021.11.014

Hitta via bibliotek

Clinical Nutrition (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Hälsovetenskap; och Näringslära

Artiklar i publikationen: Clinical Nutriti ...

Av lärosätet: Uppsala universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se